Indeed, it was recently shown that NRF2 expression and activity is reduced in the streptozotocin-induced rat model of diabetic retinopathy and that inhibition of NRF2 degradation by an inhibitor of Cullin-3 neddylation alleviates DR by counteracting oxidative stress and inflammation [46]. This evidence concerns the gene NFE2L2 and diabetic retinopathy.